A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration

Antonio J. Ruiz-Alcaraz, Hui-Kang Liu, Daniel J. Cuthbertson, Edward J. McManus, Simeen Akhtar, Christopher Lipina, Andrew D. Morris, John R. Petrie, Hari S. Hundal, Calum Sutherland

    Research output: Contribution to journalArticle

    22 Citations (Scopus)

    Abstract

    Reduced insulin-mediated glucose transport in skeletal muscle is a hallmark of the pathophysiology of T2DM (Type II diabetes mellitus). Impaired intracellular insulin signalling is implicated as a key underlying mechanism. Attention has focused on early signalling events such as defective tyrosine phosphorylation of IRS1 (insulin receptor substrate-1), a major target for the insulin receptor tyrosine kinase. This is required for normal induction of signalling pathways key to many of the metabolic actions of insulin. Conversely, increased serine/threonine phosphorylation of IRS1 following prolonged insulin exposure (or in obesity) reduces signalling capacity, partly by stimulating IRS1 degradation. We now show that IRS1 levels in human muscle are actually increased 3-fold following 1 h of hyperinsulinaemic euglycaemia. Similarly, transient induction of IRS1 (3-fold) in the liver or muscle of rodents occurs following feeding or insulin injection respectively. The induction by insulin is also observed in cell Culture systems, although to a lesser degree, and is not due to reduced proteasomal targeting, increased protein synthesis or gene transcription. Elucidation of the mechanism by which insulin promotes IRS1 stability will permit characterization of the importance of this novel signalling event in insulin regulation of liver and muscle function. Impairment of this process Would reduce IRS1 signalling capacity, thereby contributing to the development of hyperinsulinaemia/insulin resistance prior to the appearance of T2DM.

    Original languageEnglish
    Pages (from-to)345-352
    Number of pages8
    JournalBiochemical Journal
    Volume392
    DOIs
    Publication statusPublished - 1 Dec 2005

    Cite this

    Ruiz-Alcaraz, Antonio J. ; Liu, Hui-Kang ; Cuthbertson, Daniel J. ; McManus, Edward J. ; Akhtar, Simeen ; Lipina, Christopher ; Morris, Andrew D. ; Petrie, John R. ; Hundal, Hari S. ; Sutherland, Calum. / A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration. In: Biochemical Journal. 2005 ; Vol. 392. pp. 345-352.
    @article{ff2d256cf88846ee9d5e51010e3705f4,
    title = "A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration",
    abstract = "Reduced insulin-mediated glucose transport in skeletal muscle is a hallmark of the pathophysiology of T2DM (Type II diabetes mellitus). Impaired intracellular insulin signalling is implicated as a key underlying mechanism. Attention has focused on early signalling events such as defective tyrosine phosphorylation of IRS1 (insulin receptor substrate-1), a major target for the insulin receptor tyrosine kinase. This is required for normal induction of signalling pathways key to many of the metabolic actions of insulin. Conversely, increased serine/threonine phosphorylation of IRS1 following prolonged insulin exposure (or in obesity) reduces signalling capacity, partly by stimulating IRS1 degradation. We now show that IRS1 levels in human muscle are actually increased 3-fold following 1 h of hyperinsulinaemic euglycaemia. Similarly, transient induction of IRS1 (3-fold) in the liver or muscle of rodents occurs following feeding or insulin injection respectively. The induction by insulin is also observed in cell Culture systems, although to a lesser degree, and is not due to reduced proteasomal targeting, increased protein synthesis or gene transcription. Elucidation of the mechanism by which insulin promotes IRS1 stability will permit characterization of the importance of this novel signalling event in insulin regulation of liver and muscle function. Impairment of this process Would reduce IRS1 signalling capacity, thereby contributing to the development of hyperinsulinaemia/insulin resistance prior to the appearance of T2DM.",
    author = "Ruiz-Alcaraz, {Antonio J.} and Hui-Kang Liu and Cuthbertson, {Daniel J.} and McManus, {Edward J.} and Simeen Akhtar and Christopher Lipina and Morris, {Andrew D.} and Petrie, {John R.} and Hundal, {Hari S.} and Calum Sutherland",
    year = "2005",
    month = "12",
    day = "1",
    doi = "10.1042/BJ20051194",
    language = "English",
    volume = "392",
    pages = "345--352",
    journal = "Biochemical Journal",
    issn = "0264-6021",
    publisher = "Portland Press",

    }

    A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration. / Ruiz-Alcaraz, Antonio J. ; Liu, Hui-Kang; Cuthbertson, Daniel J. ; McManus, Edward J. ; Akhtar, Simeen; Lipina, Christopher; Morris, Andrew D.; Petrie, John R. ; Hundal, Hari S. ; Sutherland, Calum.

    In: Biochemical Journal, Vol. 392, 01.12.2005, p. 345-352.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration

    AU - Ruiz-Alcaraz, Antonio J.

    AU - Liu, Hui-Kang

    AU - Cuthbertson, Daniel J.

    AU - McManus, Edward J.

    AU - Akhtar, Simeen

    AU - Lipina, Christopher

    AU - Morris, Andrew D.

    AU - Petrie, John R.

    AU - Hundal, Hari S.

    AU - Sutherland, Calum

    PY - 2005/12/1

    Y1 - 2005/12/1

    N2 - Reduced insulin-mediated glucose transport in skeletal muscle is a hallmark of the pathophysiology of T2DM (Type II diabetes mellitus). Impaired intracellular insulin signalling is implicated as a key underlying mechanism. Attention has focused on early signalling events such as defective tyrosine phosphorylation of IRS1 (insulin receptor substrate-1), a major target for the insulin receptor tyrosine kinase. This is required for normal induction of signalling pathways key to many of the metabolic actions of insulin. Conversely, increased serine/threonine phosphorylation of IRS1 following prolonged insulin exposure (or in obesity) reduces signalling capacity, partly by stimulating IRS1 degradation. We now show that IRS1 levels in human muscle are actually increased 3-fold following 1 h of hyperinsulinaemic euglycaemia. Similarly, transient induction of IRS1 (3-fold) in the liver or muscle of rodents occurs following feeding or insulin injection respectively. The induction by insulin is also observed in cell Culture systems, although to a lesser degree, and is not due to reduced proteasomal targeting, increased protein synthesis or gene transcription. Elucidation of the mechanism by which insulin promotes IRS1 stability will permit characterization of the importance of this novel signalling event in insulin regulation of liver and muscle function. Impairment of this process Would reduce IRS1 signalling capacity, thereby contributing to the development of hyperinsulinaemia/insulin resistance prior to the appearance of T2DM.

    AB - Reduced insulin-mediated glucose transport in skeletal muscle is a hallmark of the pathophysiology of T2DM (Type II diabetes mellitus). Impaired intracellular insulin signalling is implicated as a key underlying mechanism. Attention has focused on early signalling events such as defective tyrosine phosphorylation of IRS1 (insulin receptor substrate-1), a major target for the insulin receptor tyrosine kinase. This is required for normal induction of signalling pathways key to many of the metabolic actions of insulin. Conversely, increased serine/threonine phosphorylation of IRS1 following prolonged insulin exposure (or in obesity) reduces signalling capacity, partly by stimulating IRS1 degradation. We now show that IRS1 levels in human muscle are actually increased 3-fold following 1 h of hyperinsulinaemic euglycaemia. Similarly, transient induction of IRS1 (3-fold) in the liver or muscle of rodents occurs following feeding or insulin injection respectively. The induction by insulin is also observed in cell Culture systems, although to a lesser degree, and is not due to reduced proteasomal targeting, increased protein synthesis or gene transcription. Elucidation of the mechanism by which insulin promotes IRS1 stability will permit characterization of the importance of this novel signalling event in insulin regulation of liver and muscle function. Impairment of this process Would reduce IRS1 signalling capacity, thereby contributing to the development of hyperinsulinaemia/insulin resistance prior to the appearance of T2DM.

    U2 - 10.1042/BJ20051194

    DO - 10.1042/BJ20051194

    M3 - Article

    C2 - 16128672

    VL - 392

    SP - 345

    EP - 352

    JO - Biochemical Journal

    JF - Biochemical Journal

    SN - 0264-6021

    ER -